Inclosin Soft Capsule (Clonixin Lysine Salt)

Adult dose

Adults: Administer 125∼250 mg of clonixin lysinate orally per dose, 3 times daily.

This medication should be consulted with a doctor or pharmacist if taken by someone who regularly consumes more than three glasses of alcohol a day, as it may increase the risk of gastrointestinal bleeding. Caution is especially needed for those with a history of heart diseases or strokes, or risk factors, as it may increase the risk of cardiovascular diseases, and consult medical personnel immediately if symptoms occur. Serious gastrointestinal diseases such as gastrointestinal bleeding, ulcers, and perforations may occur; elderly individuals or those with a history of gastrointestinal diseases should consult a specialist before taking this medication. Patients with peptic ulcers, those experiencing gastrointestinal disturbances due to medication, individuals with allergic reactions to the ingredients, those sensitive to asthma or aspirin, pregnant women or those who may become pregnant, and individuals with severe liver, kidney, or heart dysfunction should not take this medication. There is a risk of increased side effects due to interactions when taken with other nonsteroidal anti-inflammatory drugs, ACE inhibitors, aspirin, diuretics, lithium, methotrexate, anticoagulants, immunosuppressants, antidepressants, corticosteroids, etc., thus consultation with a healthcare professional is essential. If symptoms such as gastrointestinal bleeding, allergic reactions, skin rashes, liver dysfunction, blood abnormalities, or neurological symptoms occur during the course of treatment, immediately discontinue the medication and inform healthcare personnel. This medication should be administered at the minimum effective dose and for the shortest duration possible; long-term use requires regular blood tests and monitoring of liver and kidney function. Breastfeeding women should consult a specialist regarding potential secretion of this medication in breast milk, which may necessitate discontinuation of either breastfeeding or the medication itself. Keep out of the reach of children, and do not transfer to another container for safety.

Gastrointestinal bleeding, serious cardiovascular thrombotic reactions, myocardial infarction, stroke, bleeding from the stomach or intestines, ulcers, perforation, nausea, vomiting, diarrhea, constipation, abdominal pain, peptic ulcer, shock, rash, itching, anemia, elevated AST, elevated ALT, drowsiness, headache, dizziness, cold sweat, chills, atypical euphoria, jaundice, fulminant hepatitis, liver necrosis, liver failure, anemia, skin rash, exfoliative dermatitis, mucocutaneous syndrome, toxic epidermal necrolysis, severe bronchospasm

This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is best to maintain a storage temperature between 1 degree and 30 degrees Celsius at room temperature.

Appearance

A blue translucent oval soft capsule containing a transparent yellowish liquid.

Package unit

10 capsules (10 capsules/PTP X 1), 30 capsules (10 capsules/PTP X 3)